Diversified Trust Co Boosts Holdings in Waters Co. (NYSE:WAT)

Posted by on Jun 20th, 2023

Diversified Trust Co grew its holdings in shares of Waters Co. (NYSE:WAT – Get Rating) by 10.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,316 shares of the medical instruments supplier’s stock after acquiring an additional 506 shares during the quarter. Diversified Trust Co’s holdings in Waters were worth $1,646,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Itau Unibanco Holding S.A. raised its position in Waters by 22.3% in the 4th quarter. Itau Unibanco Holding S.A. now owns 181 shares of the medical instruments supplier’s stock worth $62,000 after buying an additional 33 shares during the last quarter. Summit Trail Advisors LLC increased its position in shares of Waters by 4.4% during the 4th quarter. Summit Trail Advisors LLC now owns 977 shares of the medical instruments supplier’s stock valued at $335,000 after purchasing an additional 41 shares during the last quarter. Utah Retirement Systems increased its position in shares of Waters by 0.4% during the 3rd quarter. Utah Retirement Systems now owns 10,694 shares of the medical instruments supplier’s stock valued at $2,882,000 after purchasing an additional 43 shares during the last quarter. Red Cedar Capital LLC increased its position in shares of Waters by 0.3% during the 4th quarter. Red Cedar Capital LLC now owns 16,912 shares of the medical instruments supplier’s stock valued at $5,793,000 after purchasing an additional 45 shares during the last quarter. Finally, Wetherby Asset Management Inc. increased its position in shares of Waters by 2.9% during the 1st quarter. Wetherby Asset Management Inc. now owns 1,645 shares of the medical instruments supplier’s stock valued at $511,000 after purchasing an additional 46 shares during the last quarter. 90.09% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

WAT has been the subject of several research reports. StockNews.com lowered shares of Waters from a “buy” rating to a “hold” rating in a research report on Friday, May 12th. Barclays cut their price objective on Waters from $350.00 to $325.00 in a research note on Wednesday, May 10th. Stifel Nicolaus cut their price objective on Waters from $345.00 to $315.00 in a research note on Wednesday, May 10th. Wells Fargo & Company dropped their price target on Waters from $345.00 to $305.00 in a research note on Wednesday, May 10th. Finally, Robert W. Baird dropped their price target on Waters from $345.00 to $288.00 in a research note on Wednesday, May 10th. Eight research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $335.27.

Waters Stock Up 0.4 %

Shares of WAT opened at $269.20 on Tuesday. The stock has a market capitalization of $15.89 billion, a price-to-earnings ratio of 23.39, a price-to-earnings-growth ratio of 2.84 and a beta of 0.86. Waters Co. has a 1 year low of $248.18 and a 1 year high of $369.00. The business’s 50 day simple moving average is $278.41 and its 200-day simple moving average is $309.79. The company has a debt-to-equity ratio of 2.38, a current ratio of 2.21 and a quick ratio of 1.59.

Waters (NYSE:WAT – Get Rating) last issued its quarterly earnings data on Tuesday, May 9th. The medical instruments supplier reported $2.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.60 by ($0.11). Waters had a return on equity of 149.31% and a net margin of 23.22%. The firm had revenue of $684.67 million for the quarter, compared to analysts’ expectations of $697.86 million. During the same period last year, the company earned $2.80 earnings per share. The firm’s revenue was down .9% on a year-over-year basis. As a group, equities analysts expect that Waters Co. will post 12.58 earnings per share for the current fiscal year.

Waters Profile

(Get Rating)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Articles

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT – Get Rating).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.